Cancer II. Questo articolo non è disponibile.
Lingua: inglese
Editore: Springer, 2018
- Rilegato
- Usato

Da: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Venditore AbeBooks dal 6 aprile 2009
Condizione: Usato - Come nuovo
EUR 338,59
Descrizione dell’articolo da parte del venditore
Unread book in perfect condition.
Codice articolo 30708534
- Titolo
- Cancer II
- Autore
- Waring, Mike (EDT)
- Editore
- Springer
- Anno di pubblicazione
- 2018
- Condizione
- As New
- Rilegatura
- Rilegato
- Lingua
- inglese
- ISBN 10
- 3319759248
- ISBN 13
- 9783319759241
- Serie
- Libro 28 di 38: Topics in Medicinal Chemistry
This book reviews recent breakthroughs in anti-cancer drug discovery. Building on the previous volume in the series, it outlines some of the most significant developments that have occurred in the field in the subsequent period that have led to new drug approvals or promising clinical candidates. The volume is divided into chapters that each relate to a specific protein or protein class. Each chapter provides an overview of the underlying biology and then emphasises the medicinal chemistry strategies and tactics that led to the most significant drugs and drug candidates. A summary of clinical data and the future outlook for the field is also provided. Each chapter is authored by experts in the topic and who have themselves made significant contributions to their respective fields.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Dalla quarta di copertina
This book reviews recent breakthroughs in anti-cancer drug discovery. Building on the previous volume in the series, it outlines some of the most significant developments that have occurred in the field in the subsequent period that have led to new drug approvals or promising clinical candidates. The volume is divided into chapters that each relate to a specific protein or protein class. Each chapter provides an overview of the underlying biology and then emphasises the medicinal chemistry strategies and tactics that led to the most significant drugs and drug candidates. A summary of clinical data and the future outlook for the field is also provided. Each chapter is authored by experts in the topic and who have themselves made significant contributions to their respective fields.
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.